Chronic hepatitis B virus (HBV) infection poses a substantial public health burden worldwide. Although pegylated-interferon α (PEG-IFNα) and nucleos(t)ide analogues (NAs) are available for treating ch
Additional file 1. Table 1. Instrumental variables strongly associated with CHB. Table 2. Detailed data after harmonization of instrumental variables for CHB with the SARS-CoV-2 infection dataset. Tab
Predicting hepatitis B surface antigen (HBsAg) clearance is important for chronic hepatitis B (CHB) patients receiving pegylated interferon-alfa (Peg-IFN) therapy. We aimed to determine the predictive